Your Patient Needs Cefuroxime — Now What?

You prescribed Cefuroxime for a patient with sinusitis, an ear infection, or early Lyme disease. An hour later, your office gets a call: the pharmacy doesn't have it in stock. The patient is frustrated, their infection isn't waiting, and they need a solution.

This scenario plays out regularly across practices in 2026. Cefuroxime — particularly the injectable form — has experienced intermittent shortages, and even the oral tablets can be temporarily unavailable at individual pharmacies. As a provider, having a structured approach to these situations saves time, prevents treatment delays, and improves patient satisfaction.

Current Cefuroxime Availability

Here's a quick snapshot of where things stand:

• Cefuroxime Axetil 250 mg and 500 mg tablets: Available from multiple generic manufacturers. Not in formal national shortage, but localized stockouts are common — especially during respiratory season (October through March).
• Cefuroxime Axetil oral suspension: Less commonly stocked. Many pharmacies need to special-order this formulation, which can take 1-2 business days.
• Cefuroxime Sodium injection: Intermittently on the ASHP shortage list. Manufacturing delays from key suppliers (Sagent, Hikma) have created gaps.

Why Patients Can't Find Cefuroxime

Understanding the root causes helps you anticipate and address the problem:

• Thin margins discourage manufacturers: Generic antibiotics are low-profit products. Fewer manufacturers means less redundancy in the supply chain.
• Seasonal demand surges: Cefuroxime is commonly prescribed for upper and lower respiratory infections that spike during winter months.
• Wholesaler allocation limits: During high-demand periods, drug distributors may limit how much each pharmacy can order, creating artificial scarcity at the store level.
• Patient behavior: Patients typically try only their usual pharmacy. If that one is out of stock, they may not know to check elsewhere or may call your office for help instead.

What Providers Can Do: 5 Practical Steps

Step 1: Check Stock Before You Prescribe

The single most impactful change you can make is verifying pharmacy stock before sending the prescription. Medfinder for Providers lets you check real-time Cefuroxime availability at pharmacies near your patient's address. Integrate this step into your e-prescribing workflow.

If the patient's preferred pharmacy doesn't have it, you can route the prescription to one that does — before the patient even leaves your office.

Step 2: Have a Short List of Backup Pharmacies

Keep a running list of pharmacies in your area that reliably stock Cefuroxime. Independent pharmacies are often a good bet — they work with multiple wholesalers and can be more responsive to special orders. Update this list quarterly based on feedback from patients and your pharmacy liaisons.

Step 3: Prescribe Flexibly When Clinically Appropriate

If Cefuroxime 500 mg tablets are unavailable, consider whether the 250 mg strength would work (patient takes two tablets per dose). If the patient is a child who needs suspension and it's not in stock, determine if an alternative antibiotic in suspension form (Cefdinir, Amoxicillin-Clavulanate) is appropriate.

Document your backup plan in the chart so your staff can quickly execute if the primary prescription can't be filled.

Step 4: Empower Your Front Office Staff

Train your medical assistants or front desk staff to handle "can't fill" calls efficiently:

• Check Medfinder for nearby stock and transfer the prescription
• Escalate to the prescriber only when a therapeutic alternative is needed
• Provide the patient with direct pharmacy phone numbers and Medfinder as a self-service tool

Most "can't find my medication" situations can be resolved by staff without requiring physician intervention.

Step 5: Prepare a Therapeutic Alternative Cheat Sheet

Have a quick-reference guide posted in your office or EHR for when a switch is necessary:

• Sinusitis/Otitis media: Amoxicillin-Clavulanate 875/125 mg BID, Cefdinir 300 mg BID or 600 mg daily, Cefpodoxime 200 mg BID
• Bronchitis/Pneumonia: Amoxicillin-Clavulanate, Cefdinir, or Doxycycline (if atypical coverage needed)
• UTI: Cephalexin 500 mg BID-QID, Cefpodoxime 100 mg BID, Nitrofurantoin 100 mg BID
• Early Lyme disease: Doxycycline 100 mg BID × 10-21 days (first line), Amoxicillin 500 mg TID × 14-21 days
• Skin infections: Cephalexin 500 mg QID, Dicloxacillin 500 mg QID

For a patient-facing version, direct them to alternatives to Cefuroxime.

Alternatives in Detail

When substituting Cefuroxime, the best choice depends on the infection being treated:

• Cefdinir: Third-generation cephalosporin. Good for respiratory infections, otitis media, and sinusitis. Once or twice daily dosing. Generic cost: $10-$25.
• Cefpodoxime: Third-generation cephalosporin. Broader gram-negative coverage. Good for UTIs, respiratory infections, and gonorrhea. Generic cost: $15-$35.
• Amoxicillin-Clavulanate: Penicillin + β-lactamase inhibitor. Covers similar spectrum to Cefuroxime plus anaerobes. First-line for many sinusitis and otitis media guidelines. Generic cost: $10-$30.
• Cephalexin: First-generation cephalosporin. Narrower spectrum but excellent for skin and simple UTI. Very affordable: $4-$15.

Workflow Tips for Busy Practices

• Add Medfinder to your browser bookmarks at every prescriber's workstation: medfinder.com/providers
• Create EHR templates with pre-built alternative prescriptions for common Cefuroxime indications
• Include a patient handout with your Cefuroxime prescriptions explaining what to do if the pharmacy is out of stock — include the Medfinder link and your office callback number
• Review your therapeutic interchange protocol quarterly with your pharmacy partners to stay aligned on preferred substitutes

Final Thoughts

Cefuroxime supply issues aren't going away overnight, but they're manageable with the right systems in place. Check stock before prescribing, keep backup plans ready, empower your staff, and communicate proactively with patients.

Use Medfinder for Providers to streamline the process. For the latest supply data, see our Cefuroxime shortage briefing for prescribers. And for cost-saving strategies to share with uninsured or underinsured patients, check out how to help patients save money on Cefuroxime.